Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$1.14B |
| 2 |
UnitedHealth
UNH
|
+$391M |
| 3 |
Meta Platforms (Facebook)
META
|
+$310M |
| 4 |
Wabtec
WAB
|
+$296M |
| 5 |
Elanco Animal Health
ELAN
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$518M |
| 2 |
Coca-Cola
KO
|
+$358M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$323M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$303M |
| 5 |
Starbucks
SBUX
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 17.92% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 11.03% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
1226
DELISTED
LHC Group LLC
LHCG
| $588K | ﹤0.01% |
5,308
+955
| +22% | +$102K |
|
1227
Tandem Diabetes Care
TNDM
$1.18B
| $583K | ﹤0.01% |
9,182
+3,473
| +61% | +$182K |
|
|
BEAT
1228
DELISTED
BioTelemetry, Inc.
BEAT
| $581K | ﹤0.01% |
+9,284
| New | +$638K |
|
1229
Medpace
MEDP
$16.5B
| $578K | ﹤0.01% |
+9,806
| New | +$586K |
|
|
MFGP
1230
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $577K | ﹤0.01% |
18,487
+992
| +6% | +$26.4K |
|
1231
Diageo
DEO
$47.3B
| $558K | ﹤0.01% |
3,409
| – | – |
|
1232
Eagle Materials
EXP
$6.69B
| $551K | ﹤0.01% |
6,535
+1,168
| +22% | +$84.4K |
|
|
EBIX
1233
DELISTED
Ebix Inc
EBIX
| $547K | ﹤0.01% |
11,073
+688
| +7% | +$36.3K |
|
|
AMED
1234
DELISTED
Amedisys
AMED
| $543K | ﹤0.01% |
4,404
+54
| +1% | +$6.78K |
|
1235
National Beverage
FIZZ
$2.93B
| $542K | ﹤0.01% |
18,780
+9,930
| +112% | +$353K |
|
1236
TD Synnex
SNX
$19.6B
| $538K | ﹤0.01% |
11,278
+2,512
| +29% | +$119K |
|
|
SNV
1237
DELISTED
Synovus
SNV
| $524K | ﹤0.01% |
15,260
-9,649
| -39% | -$354K |
|
1238
John B. Sanfilippo & Son
JBSS
$978M
| $510K | ﹤0.01% |
7,099
-599
| -8% | -$40K |
|
1239
Roku
ROKU
$21.2B
| $500K | ﹤0.01% |
+7,749
| New | +$414K |
|
1240
Littelfuse
LFUS
$10.2B
| $496K | ﹤0.01% |
2,720
+564
| +26% | +$104K |
|
1241
Logitech
LOGI
$15.5B
| $492K | ﹤0.01% |
12,548
| – | – |
|
1242
Simpson Manufacturing
SSD
$7.95B
| $482K | ﹤0.01% |
8,126
+433
| +6% | +$25.6K |
|
1243
CareTrust REIT
CTRE
$10.1B
| $479K | ﹤0.01% |
20,428
+5,114
| +33% | +$112K |
|
1244
Lumentum
LITE
$55.4B
| $474K | ﹤0.01% |
+8,378
| New | +$402K |
|
1245
Insight Enterprises
NSIT
$3.71B
| $474K | ﹤0.01% |
+8,610
| New | +$434K |
|
1246
Korn Ferry
KFY
$4.13B
| $460K | ﹤0.01% |
10,271
+722
| +8% | +$33K |
|
1247
SPS Commerce
SPSC
$2.41B
| $460K | ﹤0.01% |
+8,668
| New | +$425K |
|
1248
Catheter Precision
VTAK
$1.05M
| $456K | ﹤0.01% |
1
| – | – |
|
|
EXAS
1249
DELISTED
Exact Sciences
EXAS
| $449K | ﹤0.01% |
+5,187
| New | +$442K |
|
|
LOGM
1250
DELISTED
LogMein, Inc.
LOGM
| $448K | ﹤0.01% |
+5,598
| New | +$478K |
|
Similar funds
Janus Henderson Group's Q1 2019 Portfolio in Review
As of Q1 2019, Janus Henderson Group held 1,435 positions worth $180B, up 15% from $157B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q1 2019 filing shows 105 new, 637 increased, 574 reduced and 94 closed positions. Its largest new stake was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M. The largest sale was Celgene Corp, an estimated $518M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2019 buy was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M.
- Janus Henderson Group added most to Walt Disney in Q1 2019, an estimated $1.14B increase.
- Janus Henderson Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $518M.
- Janus Henderson Group fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $323M.
- Janus Henderson Group's ten largest holdings make up 17% of its $180B portfolio in Q1 2019.
- Janus Henderson Group opened 105 new positions and closed 94 in Q1 2019.
- Janus Henderson Group's portfolio value rose 15% quarter-over-quarter to $180B.
Based on Janus Henderson Group's 13F filing for Q1 2019, filed 30 Apr 2019.